A Pilot Study of Active Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer
Phase of Trial: Phase I
Latest Information Update: 19 Jul 2019
Price : $35 *
At a glance
- Drugs AVX 701 (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- 16 Jul 2019 Status changed from active, no longer recruiting to completed.
- 13 Jan 2019 Planned End Date changed from 1 Nov 2018 to 1 Jun 2019.
- 25 Jun 2017 Status changed from recruiting to active, no longer recruiting.